Open-mkt buys · 90d
$11.33M
25 trades · 5 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$11.33M
Insiders on file
20
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| ADAR1 Capital Management, LLC | 10% Owner | 11 | $7.87M | $0 | 2026-10-21 |
| Doogan Declan | Director, 10% Owner | 12 | $203.5K | $0 | 2026-09-16 |
| Giordano Christopher Thomas | CEO, Director | 16 | $60.2K | $0 | 2026-09-15 |
| STAAB THOMAS R II | Chief Financial Officer | 4 | $22.0K | $0 | 2026-09-11 |
| Schneeberger Daniel | 10% Owner | 6 | $3.20M | $0 | 2026-09-02 |
| MCGAULEY THOMAS | Interim CFO | 4 | $58.2K | $0 | 2026-01-30 |
| Rich Stuart | Chief Medical Officer | 21 | $96.4K | $0 | 2026-01-09 |
| Hunter Robyn | Director | 4 | $0 | $0 | 2026-01-09 |
| Davidson Michael H. | Director | 10 | $0 | $0 | 2026-01-09 |
| Almenoff June Sherie | Director | 9 | $29.9K | $0 | 2026-01-09 |
| PROEHL GERALD T | Director | 12 | $50.0K | $0 | 2026-01-09 |
| Armistice Capital Master Fund Ltd. | Director, 10% Owner | 16 | $45.5K | $0 | 2022-05-18 |
| Boyd Steven | Director | 2 | $0 | $0 | 2021-07-08 |
| DiTonno Anthony A | Director | 5 | $0 | $0 | 2021-07-06 |
| Mitchum James P. | Director | 6 | $50.5K | $0 | 2021-06-10 |
| Jebsen Michael B | Interim CEO, President and CFO | 20 | $0 | $0 | 2021-01-05 |
| ARMISTICE CAPITAL, LLC | Director, 10% Owner | 22 | $683.4K | $0 | 2020-09-03 |
| BLANCK RONALD R | Director | 11 | $39.0K | $5.1K | 2020-05-18 |
| RALLIS CHRIS A | Director | 3 | $0 | $0 | 2020-05-01 |
| Kelley John P | Chief Executive Officer | 3 | $0 | $0 | 2017-03-15 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| ADAR1 Capital Management, LLC | 10% Owner | P Buy | 2026-10-21 | 2026-10-21 | 331,979 | $1.66 | $550.7K | 7,447,000 | SEC↗ |
| ADAR1 Capital Management, LLC | 10% Owner | P Buy | 2026-10-20 | 2026-10-21 | 254,342 | $1.60 | $405.7K | 7,115,021 | SEC↗ |
| ADAR1 Capital Management, LLC | 10% Owner | P Buy | 2026-10-19 | 2026-10-21 | 336,528 | $1.51 | $507.0K | 6,860,679 | SEC↗ |
| Doogan Declan | Director | P Buy | 2026-09-16 | 2026-09-17 | 53,000 | $1.92 | $101.8K | 55,274 | SEC↗ |
| Doogan Declan | Director | P Buy | 2026-09-16 | 2026-09-17 | 53,000 | $1.92 | $101.8K | 55,274 | SEC↗ |
| Giordano Christopher Thomas | CEO | P Buy | 2026-09-15 | 2026-09-15 | 4,850 | $1.82 | $8.8K | 22,174 | SEC↗ |
| Giordano Christopher Thomas | CEO, Director | P Buy | 2026-09-15 | 2026-09-15 | 4,850 | $1.82 | $8.8K | 22,174 | SEC↗ |
| STAAB THOMAS R II | Chief Financial Officer | P Buy | 2026-09-11 | 2026-09-15 | 5,675 | $1.94 | $11.0K | 15,675 | SEC↗ |
| Giordano Christopher Thomas | CEO | P Buy | 2026-09-11 | 2026-09-15 | 6,000 | $1.88 | $11.3K | 17,324 | SEC↗ |
| STAAB THOMAS R II | Chief Financial Officer | P Buy | 2026-09-11 | 2026-09-15 | 5,675 | $1.94 | $11.0K | 15,675 | SEC↗ |
| Giordano Christopher Thomas | CEO, Director | P Buy | 2026-09-11 | 2026-09-15 | 6,000 | $1.88 | $11.3K | 17,324 | SEC↗ |
| ADAR1 Capital Management, LLC | 10% Owner | P Buy | 2026-09-03 | 2026-09-08 | 900,000 | $1.78 | $1.60M | 6,524,151 | SEC↗ |
| ADAR1 Capital Management, LLC | 10% Owner | P Buy | 2026-09-03 | 2026-09-08 | 900,000 | $1.78 | $1.60M | 6,524,151 | SEC↗ |
| Schneeberger Daniel | 10% Owner | P Buy | 2026-09-02 | 2026-09-02 | 187,704 | $1.80 | $337.9K | 5,624,151 | SEC↗ |
| ADAR1 Capital Management, LLC | 10% Owner | P Buy | 2026-09-02 | 2026-09-02 | 187,704 | $1.80 | $337.6K | 5,624,151 | SEC↗ |
| Schneeberger Daniel | 10% Owner | P Buy | 2026-09-01 | 2026-09-02 | 179,058 | $1.80 | $322.3K | 5,436,447 | SEC↗ |
| ADAR1 Capital Management, LLC | 10% Owner | P Buy | 2026-09-01 | 2026-09-02 | 179,058 | $1.80 | $321.6K | 5,436,447 | SEC↗ |
| Schneeberger Daniel | 10% Owner | P Buy | 2026-08-31 | 2026-09-02 | 403,571 | $1.79 | $722.4K | 5,257,389 | SEC↗ |
| ADAR1 Capital Management, LLC | 10% Owner | P Buy | 2026-08-31 | 2026-09-02 | 403,571 | $1.79 | $722.6K | 5,257,389 | SEC↗ |
| Schneeberger Daniel | 10% Owner | P Buy | 2026-08-24 | 2026-08-24 | 107,374 | $1.75 | $187.9K | 4,853,818 | SEC↗ |
| ADAR1 Capital Management, LLC | 10% Owner | P Buy | 2026-08-24 | 2026-08-24 | 107,374 | $1.75 | $188.4K | 4,853,818 | SEC↗ |
| Schneeberger Daniel | 10% Owner | P Buy | 2026-08-21 | 2026-08-24 | 716,369 | $1.77 | $1.27M | 4,746,444 | SEC↗ |
| ADAR1 Capital Management, LLC | 10% Owner | P Buy | 2026-08-21 | 2026-08-24 | 716,369 | $1.77 | $1.27M | 4,746,444 | SEC↗ |
| Schneeberger Daniel | 10% Owner | P Buy | 2026-08-20 | 2026-08-24 | 202,124 | $1.78 | $359.8K | 4,030,075 | SEC↗ |
| ADAR1 Capital Management, LLC | 10% Owner | P Buy | 2026-08-20 | 2026-08-24 | 202,124 | $1.78 | $359.5K | 4,030,075 | SEC↗ |
| Giordano Christopher Thomas | CEO | M Exercise deriv | 2026-07-13 | 2026-07-14 | 219 | — | $0 | 218 | SEC↗ |
| Giordano Christopher Thomas | CEO | M Exercise deriv | 2026-07-13 | 2026-07-14 | 8,500 | — | $0 | 1,241,500 | SEC↗ |
| Giordano Christopher Thomas | CEO | M Exercise | 2026-07-13 | 2026-07-14 | 8,500 | $5.94 | $50.5K | 11,324 | SEC↗ |
| Giordano Christopher Thomas | CEO | M Exercise | 2026-07-13 | 2026-07-14 | 219 | $3.55 | $777 | 2,824 | SEC↗ |
| STAAB THOMAS R II | Chief Financial Officer | A Award deriv | 2026-05-11 | 2026-05-13 | 450,000 | — | $0 | 450,000 | SEC↗ |
| STAAB THOMAS R II | Chief Financial Officer | A Award | 2026-05-11 | 2026-05-13 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MCGAULEY THOMAS | Interim CFO | M Exercise deriv | 2026-01-30 | 2026-02-03 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Hunter Robyn | Director | A Award deriv | 2026-01-09 | 2026-01-13 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Doogan Declan | Director | A Award deriv | 2026-01-09 | 2026-01-13 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Almenoff June Sherie | Director | A Award deriv | 2026-01-09 | 2026-01-13 | 30,000 | — | $0 | 30,000 | SEC↗ |
| PROEHL GERALD T | Director | A Award deriv | 2026-01-09 | 2026-01-13 | 3,000 | — | $0 | 30,000 | SEC↗ |
| Rich Stuart | Chief Medical Officer | A Award deriv | 2026-01-09 | 2026-01-13 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Giordano Christopher Thomas | CEO | A Award deriv | 2026-01-09 | 2026-01-13 | 450,000 | — | $0 | 450,000 | SEC↗ |
| Davidson Michael H. | Director | A Award deriv | 2026-01-09 | 2026-01-13 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Rich Stuart | Chief Medical Officer | P Buy | 2025-12-09 | 2025-12-10 | 2,500 | $10.22 | $25.6K | 5,266 | SEC↗ |
| Rich Stuart | Chief Medical Officer | P Buy | 2025-12-08 | 2025-12-10 | 2,500 | $10.10 | $25.3K | 5,000 | SEC↗ |
| Rich Stuart | Chief Medical Officer | P Buy | 2025-12-04 | 2025-12-05 | 2,500 | $9.20 | $23.0K | 2,500 | SEC↗ |
| Rich Stuart | Chief Medical Officer | P Buy | 2025-12-03 | 2025-12-05 | 1,500 | $9.08 | $13.6K | 2,766 | SEC↗ |
| Rich Stuart | Chief Medical Officer | P Buy | 2025-12-02 | 2025-12-05 | 1,000 | $9.01 | $9.0K | 1,266 | SEC↗ |
| Giordano Christopher Thomas | CEO | P Buy | 2025-11-20 | 2025-11-20 | 538 | $7.59 | $4.1K | 2,605 | SEC↗ |
| Giordano Christopher Thomas | CEO | P Buy | 2025-11-19 | 2025-11-20 | 455 | $7.51 | $3.4K | 2,067 | SEC↗ |
| Almenoff June Sherie | Director | P Buy | 2025-11-18 | 2025-11-19 | 1,900 | $7.52 | $14.3K | 1,993 | SEC↗ |
| Almenoff June Sherie | Director | P Buy | 2025-11-18 | 2025-11-20 | 1,900 | $7.52 | $14.3K | 1,993 | SEC↗ |
| Giordano Christopher Thomas | CEO | P Buy | 2025-11-18 | 2025-11-20 | 1,612 | $7.75 | $12.5K | 1,612 | SEC↗ |
| Almenoff June Sherie | Director | P Buy | 2025-11-17 | 2025-11-19 | 93 | $7.15 | $665 | 93 | SEC↗ |
| MCGAULEY THOMAS | Interim CFO | P Buy | 2025-11-17 | 2025-11-19 | 2,000 | $7.34 | $14.7K | 2,000 | SEC↗ |
| MCGAULEY THOMAS | Interim CFO | P Buy | 2025-11-17 | 2025-11-19 | 1,000 | $7.35 | $7.3K | 1,000 | SEC↗ |
| MCGAULEY THOMAS | Interim CFO | P Buy | 2025-11-17 | 2025-11-19 | 5,000 | $7.23 | $36.1K | 5,000 | SEC↗ |
| Almenoff June Sherie | Director | P Buy | 2025-11-17 | 2025-11-20 | 93 | $7.15 | $665 | 93 | SEC↗ |
| Hunter Robyn | Director | A Award deriv | 2025-07-01 | 2025-07-03 | 80,000 | — | $0 | 80,000 | SEC↗ |
| PROEHL GERALD T | Director | A Award deriv | 2025-07-01 | 2025-07-03 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Doogan Declan | Director | A Award deriv | 2025-07-01 | 2025-07-03 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Davidson Michael H. | Director | A Award deriv | 2025-07-01 | 2025-07-03 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Almenoff June Sherie | Director | A Award deriv | 2025-07-01 | 2025-07-03 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Giordano Christopher Thomas | CEO | A Award deriv | 2025-05-16 | 2025-05-20 | 1,400,000 | — | $0 | 1,400,000 | SEC↗ |
| Rich Stuart | Chief Medical Officer | A Award deriv | 2025-05-16 | 2025-05-20 | 625,000 | — | $0 | 625,000 | SEC↗ |
| Almenoff June Sherie | Director | A Award deriv | 2024-12-10 | 2024-12-12 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Davidson Michael H. | Director | A Award deriv | 2024-12-10 | 2024-12-12 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Doogan Declan | Director | A Award deriv | 2024-12-10 | 2024-12-12 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Giordano Christopher Thomas | CEO | A Award deriv | 2024-12-10 | 2024-12-12 | 1,250,000 | — | $0 | 1,250,000 | SEC↗ |
| Hunter Robyn | Director | A Award deriv | 2024-12-10 | 2024-12-12 | 100,000 | — | $0 | 100,000 | SEC↗ |
| PROEHL GERALD T | Director | A Award deriv | 2024-12-10 | 2024-12-12 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Rich Stuart | Chief Medical Officer | A Award deriv | 2024-12-10 | 2024-12-12 | 500,000 | — | $0 | 500,000 | SEC↗ |
| Davidson Michael H. | Director | P Buy deriv | 2024-08-08 | 2024-08-08 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Davidson Michael H. | Director | P Buy deriv | 2024-08-08 | 2024-08-08 | 47,500 | — | $0 | 47,500 | SEC↗ |
| PROEHL GERALD T | Director | P Buy deriv | 2024-08-08 | 2024-08-08 | 16,660 | — | $0 | 16,660 | SEC↗ |
| PROEHL GERALD T | Director | P Buy deriv | 2024-08-08 | 2024-08-08 | 31,654 | — | $0 | 31,654 | SEC↗ |
| Davidson Michael H. | Director | P Buy | 2024-08-08 | 2024-08-08 | 2,500 | — | $0 | 2,881 | SEC↗ |
| PROEHL GERALD T | Director | P Buy | 2024-08-08 | 2024-08-08 | 1,666 | — | $0 | 1,667 | SEC↗ |
| Giordano Christopher Thomas | CEO | A Award deriv | 2024-05-17 | 2024-05-21 | 437 | — | $0 | 437 | SEC↗ |
| Rich Stuart | Chief Medical Officer | A Award deriv | 2024-05-17 | 2024-05-21 | 119 | — | $0 | 119 | SEC↗ |
| Rich Stuart | Chief Medical Officer | G Gift | 2022-09-21 | 2022-09-23 | 1,909,585 | — | $0 | 1,909,585 | SEC↗ |
| Rich Stuart | Chief Medical Officer | G Gift | 2022-09-21 | 2022-09-23 | 1,909,585 | — | $0 | 424,347 | SEC↗ |
| Doogan Declan | Director, 10% Owner | G Gift | 2022-08-11 | 2022-08-12 | 567,871 | — | $0 | 0 | SEC↗ |
| Doogan Declan | Director, 10% Owner | G Gift | 2022-08-11 | 2022-08-12 | 567,871 | — | $0 | 3,637,871 | SEC↗ |
| Almenoff June Sherie | Director | A Award deriv | 2022-06-09 | 2022-06-10 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Davidson Michael H. | Director | A Award deriv | 2022-06-09 | 2022-06-10 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Doogan Declan | Director, 10% Owner | A Award deriv | 2022-06-09 | 2022-06-10 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Giordano Christopher Thomas | CEO | A Award deriv | 2022-06-09 | 2022-06-10 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Hunter Robyn | Director | A Award deriv | 2022-06-09 | 2022-06-10 | 6,250 | — | $0 | 6,250 | SEC↗ |
| PROEHL GERALD T | Director | A Award deriv | 2022-06-09 | 2022-06-10 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Rich Stuart | Chief Medical Officer | A Award deriv | 2022-06-09 | 2022-06-10 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Armistice Capital Master Fund | Director, 10% Owner | D To issuer deriv | 2022-05-18 | 2022-05-19 | 2,360,313 | — | $0 | 0 | SEC↗ |
| Armistice Capital Master Fund | Director, 10% Owner | D To issuer deriv | 2022-05-18 | 2022-05-19 | 4,773,269 | — | $0 | 0 | SEC↗ |
| Armistice Capital Master Fund | Director, 10% Owner | A Award deriv | 2022-05-18 | 2022-05-19 | 10,596,027 | — | $0 | 10,596,027 | SEC↗ |
| Armistice Capital Master Fund | Director, 10% Owner | D To issuer deriv | 2022-05-18 | 2022-05-19 | 3,175,924 | — | $0 | 0 | SEC↗ |
| Armistice Capital Master Fund | Director, 10% Owner | A Award deriv | 2022-05-18 | 2022-05-19 | 3,175,924 | — | $0 | 3,175,924 | SEC↗ |
| Armistice Capital Master Fund | Director, 10% Owner | D To issuer deriv | 2022-05-18 | 2022-05-19 | 4,607,692 | — | $0 | 0 | SEC↗ |
| Armistice Capital Master Fund | Director, 10% Owner | A Award deriv | 2022-05-18 | 2022-05-19 | 10,596,027 | — | $0 | 10,596,027 | SEC↗ |
| Armistice Capital Master Fund | Director, 10% Owner | A Award deriv | 2022-05-18 | 2022-05-19 | 4,607,692 | — | $0 | 4,607,692 | SEC↗ |
| Armistice Capital Master Fund | Director, 10% Owner | A Award deriv | 2022-05-18 | 2022-05-19 | 4,773,269 | — | $0 | 4,773,269 | SEC↗ |
| Armistice Capital Master Fund | Director, 10% Owner | A Award deriv | 2022-05-18 | 2022-05-19 | 2,360,313 | — | $0 | 2,360,313 | SEC↗ |
| Armistice Capital Master Fund | Director, 10% Owner | D To issuer deriv | 2022-05-18 | 2022-05-19 | 2,072,538 | — | $0 | 0 | SEC↗ |
| Armistice Capital Master Fund | Director, 10% Owner | A Award deriv | 2022-05-18 | 2022-05-19 | 2,072,538 | — | $0 | 2,072,538 | SEC↗ |
| Rich Stuart | Chief Medical Officer | G Gift | 2021-11-29 | 2021-12-06 | 1,909,585 | — | $0 | 0 | SEC↗ |
| Rich Stuart | Chief Medical Officer | G Gift | 2021-11-29 | 2021-12-06 | 1,909,585 | — | $0 | 1,909,585 | SEC↗ |
| Rich Stuart | Chief Medical Officer | G Gift | 2021-10-12 | 2021-12-06 | 1,909,585 | — | $0 | 2,333,932 | SEC↗ |
| Rich Stuart | Chief Medical Officer | G Gift | 2021-10-12 | 2021-12-06 | 1,909,585 | — | $0 | 1,909,585 | SEC↗ |
| Boyd Steven | Director | A Award deriv | 2021-07-08 | 2021-07-09 | 4,773,269 | — | $0 | 4,773,269 | SEC↗ |
| Boyd Steven | Director | A Award deriv | 2021-07-08 | 2021-07-09 | 4,773,269 | — | $0 | 4,773,269 | SEC↗ |
| DiTonno Anthony A | CEO | A Award deriv | 2021-07-06 | 2021-07-08 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Doogan Declan | Director, 10% Owner | G Gift | 2021-06-30 | 2021-08-11 | 567,871 | — | $0 | 2,502,129 | SEC↗ |
| Doogan Declan | Director, 10% Owner | M Exercise deriv | 2021-06-11 | 2021-06-15 | 3,070 | — | $0 | 0 | SEC↗ |
| Davidson Michael H. | Director | M Exercise deriv | 2021-06-11 | 2021-06-15 | 512 | — | $0 | 0 | SEC↗ |
| Rich Stuart | Chief Medical Officer | M Exercise deriv | 2021-06-11 | 2021-06-15 | 3,581 | — | $0 | 0 | SEC↗ |
| Doogan Declan | Director, 10% Owner | M Exercise | 2021-06-11 | 2021-06-15 | 3,070,000 | — | $0 | 3,637,871 | SEC↗ |
| Davidson Michael H. | Director | A Award | 2021-06-11 | 2021-06-15 | 512,000 | — | $0 | 606,645 | SEC↗ |
| Rich Stuart | Chief Medical Officer | M Exercise | 2021-06-11 | 2021-06-15 | 3,581,000 | — | $0 | 4,243,517 | SEC↗ |
| Doogan Declan | Director, 10% Owner | A Award deriv | 2021-06-10 | 2021-06-15 | 6,250 | — | $0 | 6,250 | SEC↗ |
| PROEHL GERALD T | Director | A Award deriv | 2021-06-10 | 2021-06-15 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Davidson Michael H. | Director | A Award deriv | 2021-06-10 | 2021-06-15 | 6,250 | — | $0 | 6,250 | SEC↗ |
| Mitchum James P. | Director | A Award deriv | 2021-06-10 | 2021-06-15 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Almenoff June Sherie | Director | A Award deriv | 2021-06-10 | 2021-06-15 | 6,250 | — | $0 | 6,250 | SEC↗ |
| Rich Stuart | Chief Medical Officer | A Award deriv | 2021-01-15 | 2021-01-27 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Rich Stuart | Chief Medical Officer | A Award | 2021-01-15 | 2021-01-27 | 3,581 | — | $0 | 3,581 | SEC↗ |
| Rich Stuart | Chief Medical Officer | A Award | 2021-01-15 | 2021-01-27 | 662,517 | — | $0 | 662,517 | SEC↗ |
| Jebsen Michael B | CFO | A Award deriv | 2021-01-05 | 2021-01-12 | 70,000 | — | $0 | 70,000 | SEC↗ |
| DiTonno Anthony A | CEO | A Award deriv | 2021-01-05 | 2021-01-12 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Armistice Capital Master Fund | Director, 10% Owner | P Buy | 2020-09-08 | 2020-09-09 | 8,543 | $1.46 | $12.5K | 2,019,995 | SEC↗ |
| Armistice Capital Master Fund | Director, 10% Owner | P Buy | 2020-09-08 | 2020-09-09 | 0 | — | $0 | 2,019,995 | SEC↗ |
| Armistice Capital Master Fund | Director, 10% Owner | P Buy | 2020-09-04 | 2020-09-09 | 0 | — | $0 | 2,011,452 | SEC↗ |
| Armistice Capital Master Fund | Director, 10% Owner | P Buy | 2020-09-04 | 2020-09-09 | 23,457 | $1.41 | $33.1K | 2,011,452 | SEC↗ |
| ARMISTICE CAPITAL, LLC | Director, 10% Owner | P Buy | 2020-09-03 | 2020-09-03 | 0 | — | $0 | 1,987,995 | SEC↗ |
| ARMISTICE CAPITAL, LLC | Director, 10% Owner | P Buy | 2020-09-03 | 2020-09-03 | 36,000 | $1.39 | $50.0K | 1,987,995 | SEC↗ |
| ARMISTICE CAPITAL, LLC | Director, 10% Owner | P Buy | 2020-09-02 | 2020-09-03 | 20,000 | $1.47 | $29.4K | 1,951,995 | SEC↗ |
| ARMISTICE CAPITAL, LLC | Director, 10% Owner | P Buy | 2020-09-02 | 2020-09-03 | 0 | — | $0 | 1,951,995 | SEC↗ |
| ARMISTICE CAPITAL, LLC | Director, 10% Owner | P Buy | 2020-09-01 | 2020-09-03 | 0 | — | $0 | 1,931,995 | SEC↗ |
| ARMISTICE CAPITAL, LLC | Director, 10% Owner | P Buy | 2020-09-01 | 2020-09-03 | 30,000 | $1.46 | $43.8K | 1,931,995 | SEC↗ |
| ARMISTICE CAPITAL, LLC | Director, 10% Owner | P Buy | 2020-08-31 | 2020-08-31 | 20,000 | $1.45 | $29.0K | 1,901,995 | SEC↗ |
| ARMISTICE CAPITAL, LLC | Director, 10% Owner | P Buy | 2020-08-31 | 2020-08-31 | 0 | — | $0 | 1,901,995 | SEC↗ |
| ARMISTICE CAPITAL, LLC | Director, 10% Owner | P Buy | 2020-08-27 | 2020-08-31 | 12,000 | $1.50 | $18.0K | 1,881,995 | SEC↗ |
| ARMISTICE CAPITAL, LLC | Director, 10% Owner | P Buy | 2020-08-27 | 2020-08-31 | 0 | — | $0 | 1,881,995 | SEC↗ |
| ARMISTICE CAPITAL, LLC | 10% Owner | P Buy | 2020-08-26 | 2020-08-26 | 12,000 | $1.50 | $18.0K | 1,869,995 | SEC↗ |
| ARMISTICE CAPITAL, LLC | 10% Owner | P Buy | 2020-08-26 | 2020-08-26 | 0 | — | $0 | 1,869,995 | SEC↗ |
| ARMISTICE CAPITAL, LLC | 10% Owner | P Buy | 2020-08-25 | 2020-08-26 | 17,211 | $1.53 | $26.3K | 1,857,995 | SEC↗ |
| ARMISTICE CAPITAL, LLC | 10% Owner | P Buy | 2020-08-25 | 2020-08-26 | 0 | — | $0 | 1,857,995 | SEC↗ |
| ARMISTICE CAPITAL, LLC | 10% Owner | P Buy | 2020-08-24 | 2020-08-26 | 5,692 | $1.47 | $8.4K | 1,840,784 | SEC↗ |
| ARMISTICE CAPITAL, LLC | 10% Owner | P Buy | 2020-08-24 | 2020-08-26 | 0 | — | $0 | 1,840,784 | SEC↗ |
| ARMISTICE CAPITAL, LLC | Director, 10% Owner | P Buy | 2020-08-21 | 2020-08-21 | 116,242 | $1.44 | $167.4K | 1,835,092 | SEC↗ |
| ARMISTICE CAPITAL, LLC | Director, 10% Owner | P Buy | 2020-08-21 | 2020-08-21 | 0 | — | $0 | 1,835,092 | SEC↗ |
| ARMISTICE CAPITAL, LLC | Director, 10% Owner | P Buy | 2020-08-20 | 2020-08-21 | 124,472 | $1.53 | $190.4K | 1,718,850 | SEC↗ |
| ARMISTICE CAPITAL, LLC | Director, 10% Owner | P Buy | 2020-08-20 | 2020-08-21 | 0 | — | $0 | 1,718,850 | SEC↗ |
| ARMISTICE CAPITAL, LLC | Director, 10% Owner | P Buy | 2020-08-19 | 2020-08-21 | 0 | — | $0 | 1,594,378 | SEC↗ |
| ARMISTICE CAPITAL, LLC | Director, 10% Owner | P Buy | 2020-08-19 | 2020-08-21 | 70,767 | $1.45 | $102.6K | 1,594,378 | SEC↗ |
| BLANCK RONALD R | Director | P Buy | 2020-05-18 | 2020-05-19 | 5,000 | $0.95 | $4.8K | 6,062 | SEC↗ |
| BLANCK RONALD R | Director | A Award deriv | 2020-05-01 | 2020-05-15 | 500 | — | $0 | 500 | SEC↗ |
| Mitchum James P. | Director | A Award deriv | 2020-05-01 | 2020-05-15 | 500 | — | $0 | 500 | SEC↗ |
| PROEHL GERALD T | Director | A Award deriv | 2020-05-01 | 2020-05-15 | 500 | — | $0 | 500 | SEC↗ |
| RALLIS CHRIS A | Director | A Award deriv | 2020-05-01 | 2020-06-15 | 500 | — | $0 | 500 | SEC↗ |
| DiTonno Anthony A | CEO | A Award deriv | 2020-03-01 | 2020-05-15 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Jebsen Michael B | CFO | A Award deriv | 2020-03-01 | 2020-05-15 | 75,000 | — | $0 | 75,000 | SEC↗ |
| RALLIS CHRIS A | Director | A Award deriv | 2019-05-01 | 2020-06-15 | 500 | — | $0 | 500 | SEC↗ |
| Jebsen Michael B | CFO | D To issuer | 2018-07-31 | 2018-08-07 | 5,720 | $6.25 | $35.8K | 34,680 | SEC↗ |
| DiTonno Anthony A | CEO | A Award deriv | 2018-06-01 | 2019-04-22 | 50,000 | — | $0 | 50,000 | SEC↗ |
| PROEHL GERALD T | Director | A Award deriv | 2018-05-01 | 2019-04-18 | 500 | — | $0 | 500 | SEC↗ |
| BLANCK RONALD R | Director | A Award deriv | 2018-05-01 | 2019-04-18 | 500 | — | $0 | 500 | SEC↗ |
| DiTonno Anthony A | Director | A Award deriv | 2018-05-01 | 2019-04-18 | 500 | — | $0 | 500 | SEC↗ |
| Mitchum James P. | Director | A Award deriv | 2018-05-01 | 2019-04-18 | 500 | — | $0 | 500 | SEC↗ |
| Jebsen Michael B | CFO | D To issuer | 2018-03-30 | 2018-04-05 | 6,425 | $5.42 | $34.8K | 12,310 | SEC↗ |
| Jebsen Michael B | CFO | D To issuer | 2017-12-29 | 2018-01-02 | 98 | $0.43 | $42 | 68,264 | SEC↗ |
| BLANCK RONALD R | Director | P Buy | 2017-12-18 | 2017-12-20 | 6,475 | $0.45 | $2.9K | 20,099 | SEC↗ |
| BLANCK RONALD R | Director | P Buy | 2017-12-18 | 2017-12-20 | 6,475 | $0.46 | $3.0K | 13,624 | SEC↗ |
| BLANCK RONALD R | Director | S Sale | 2017-11-14 | 2017-11-20 | 12,950 | $0.39 | $5.1K | 7,149 | SEC↗ |
| Jebsen Michael B | CFO | D To issuer | 2017-07-31 | 2017-07-31 | 54 | $0.65 | $35 | 68,146 | SEC↗ |
| Jebsen Michael B | CFO | D To issuer | 2017-04-15 | 2017-04-18 | 56 | $0.54 | $30 | 68,200 | SEC↗ |
| Jebsen Michael B | Interim CEO, President and C | A Award deriv | 2017-04-03 | 2017-04-05 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Kelley John P | Chief Executive Officer | F Tax w/h | 2017-03-15 | 2017-03-20 | 96,999 | $0.68 | $66.0K | 1,282,932 | SEC↗ |
| Kelley John P | Chief Executive Officer | A Award | 2017-03-15 | 2017-03-20 | 213,420 | — | $0 | 1,379,931 | SEC↗ |
| Jebsen Michael B | CFO | D To issuer | 2016-12-19 | 2016-12-20 | 49 | $2.07 | $101 | 68,256 | SEC↗ |
| Kelley John P | Chief Executive Officer | A Award deriv | 2016-12-15 | 2016-12-20 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Jebsen Michael B | Chief Financial Officer | A Award deriv | 2016-12-15 | 2016-12-20 | 150,000 | — | $0 | 150,000 | SEC↗ |
| PROEHL GERALD T | Director | P Buy | 2016-11-23 | 2016-11-29 | 14,449 | $1.76 | $25.4K | 29,882 | SEC↗ |
| PROEHL GERALD T | Director | P Buy | 2016-11-22 | 2016-11-29 | 15,433 | $1.59 | $24.5K | 15,433 | SEC↗ |
| Mitchum James P. | Director | D To issuer | 2016-11-21 | 2016-11-22 | 7,000 | $1.51 | $10.6K | 26,000 | SEC↗ |
| Jebsen Michael B | CFO | D To issuer | 2016-09-30 | 2016-10-20 | 49 | $2.32 | $114 | 68,305 | SEC↗ |
| RALLIS CHRIS A | Director | D To issuer | 2016-08-19 | 2016-08-22 | 10,000 | $2.50 | $25.0K | 14,490 | SEC↗ |
| Jebsen Michael B | CFO | D To issuer | 2016-06-01 | 2016-10-20 | 55 | $2.72 | $150 | 68,354 | SEC↗ |
| BLANCK RONALD R | Director | D To issuer | 2016-05-23 | 2016-05-27 | 3,500 | $2.62 | $9.2K | 20,099 | SEC↗ |
| Jebsen Michael B | CFO | A Award | 2016-05-01 | 2016-10-20 | 430 | $2.72 | $1.2K | 68,409 | SEC↗ |
| Mitchum James P. | Director | P Buy | 2016-02-03 | 2016-02-19 | 13,900 | $2.65 | $36.8K | 19,000 | SEC↗ |
| BLANCK RONALD R | Director | D To issuer | 2016-02-02 | 2016-04-06 | 1,800 | $2.69 | $4.8K | 16,599 | SEC↗ |
| Mitchum James P. | Director | P Buy | 2016-02-02 | 2016-02-19 | 5,100 | $2.68 | $13.7K | 5,100 | SEC↗ |
| Jebsen Michael B | CFO | D To issuer | 2016-01-29 | 2016-04-04 | 56 | $2.65 | $148 | 67,979 | SEC↗ |
| BLANCK RONALD R | Director | P Buy | 2015-11-19 | 2015-11-19 | 4,700 | $3.26 | $15.3K | 12,899 | SEC↗ |
| BLANCK RONALD R | Director | P Buy | 2015-11-19 | 2015-11-19 | 1,900 | $3.20 | $6.1K | 14,799 | SEC↗ |
| Jebsen Michael B | CFO | D To issuer | 2015-10-31 | 2015-11-09 | 49 | $3.19 | $156 | 68,035 | SEC↗ |
| Jebsen Michael B | CFO | D To issuer | 2015-07-31 | 2015-08-18 | 49 | $3.68 | $180 | 68,084 | SEC↗ |
| Jebsen Michael B | CFO | D To issuer | 2015-05-15 | 2015-05-15 | 55 | $3.44 | $189 | 67,703 | SEC↗ |
| Jebsen Michael B | CFO | D To issuer | 2015-05-15 | 2015-06-26 | 430 | $3.42 | $1.5K | 68,133 | SEC↗ |
| Jebsen Michael B | CFO | D To issuer | 2015-02-13 | 2015-02-18 | 56 | $3.28 | $184 | 67,758 | SEC↗ |
| BLANCK RONALD R | Director | P Buy | 2015-01-20 | 2015-01-20 | 2,000 | $3.49 | $7.0K | 10,199 | SEC↗ |
| Jebsen Michael B | CFO | D To issuer | 2014-10-31 | 2014-12-02 | 49 | $3.94 | $193 | 67,814 | SEC↗ |